Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Heinrich Brüssow named as Kovsie Alumnus of the Year
2010-08-19

Ms Jackie Ntshingila  Prof. Teuns Verschoor  Prof. Benito Khotseng  Heinrich Brüssow 

The Alumni of the University of the Free State (UFS) have named Heinrich Brüssow as the Kovsie Alumnus of the Year for 2009.

At the same time, Ms Jackie Ntshingila, the Provincial Manager of the Small Enterprise Development Agency (SEDA), will receive the Kovsie Alumni Cum Laude Award, while the Executive Management Award will be awarded to Prof. Teuns Verschoor, acting Senior Vice-Rector at the UFS, and Prof. Benito Khotseng. These awards, which are made annually to honour alumni of the UFS for their exceptional achievements and contributions to the university, will be awarded on Friday, 3 September 2010.

Heinrich is currently one of the most formidable Free State Cheetahs players. During the international Super 14 Competition he was a pillar of strength for his team in many respects. He was one of the outstanding players in the match between the Springboks and the Lions. He has established himself in the triumphant Springbok team as one of the definite choices. He received the Man-of-the-Match award in the Springboks’ victory over the All Blacks on 25 July 2009, as well as the awards as the Provincial Player of the Castle SA 2009 Tournament, the SA Rugby Young Player of the Year 2009 and the 2009 Sports24 Performer of the Month.

Ms Ntshingila will receive the Kovsie Alumni Cum Laude Award for her role in the business development sector in the Free State and particularly the empowerment of women in the business sector. Her constructive inputs on various committees have lead to the outstanding role that she has played to expand SEDA in the Free State from 1 to 56 members and five branches during a relatively short period.

Prof. Verschoor will receive an Executive Management Award for the tremendous role he has played in many student matters, research, transformation and other university matters. Recognition is also given to the role that he fulfilled as acting Rector of the university during 2008-2009. In this he has emphasised his passion and commitment towards the university. In 2004 he received a Centenary Medal for management, diversity and student transformation.

Prof. Khotseng will receive an Executive Management Award for his influential and leading role during the 1990s, when the UFS was established as an outstanding institution. Prof. Khotseng played a leading and influential role as Vice-Rector: Student Affairs. He has served on the UFS Council from 1993 and in 1994 he accepted the position as Senior Manager: Strategic Programmes at Kovsies. He managed transformation and the marketing of the university in the black community with distinction. In 1995 he helped to diffuse the conflict in residences and to create a culture of learning. With the help of the Multicultural and Transformation Committees he taught persons to respect and understand one another. In 2004 he also received a Centenary Medal. 

The coveted Kovsie Alumni Awards will be handed over at a Kovsie Alumni breakfast. All alumni are welcome at the breakfast which will take place in the Reitz Hall of the UFS Centenary Complex. The cost is R50 per person and includes a delicious breakfast. If you are interested in attending, please contact Annanda Calitz at 051 401 3382 or ficka@ufs.ac.za  
 
Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
19 August 2010

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept